AEGEAN
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
AEGEAN
Sep 13, 2024, 12:55 |
Blog
Shubh G: NeoCOAST and AEGEAN trial results at WCLC
Shubh G, VP, US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Sep 5, 2024, 14:56 |
Blog
Shubh Goel: What to expect from AstraZeneca at WCLC and ESMO
Shubh Goel, VP, US Franchise Head, ImmunoOncology and GI Tumors at AstraZeneca, shared a post…
Aug 24, 2024, 13:58 |
Insight
Jennifer Marks: The new NSCLCÂ FDA Oncology approvals
Jennifer Marks, Thoracic Oncologist at Georgetown Lombardi, shared a post on X, referencing an earlier…
Jul 27, 2024, 02:50 |
Blog
Patrick Forde: Interesting ODAC for future perioperative trial designs
Patrick Forde, Professor at the Johns Hopkins University, shared a post on X by FDA…
May 1, 2024, 09:08 |
Insight
Piotr Wysocki: Adjuvant immunotherapy in NSCLC patients who underwent radical resection preceded by immunotherapy
Piotr Wysocki recently shared on LinkedIn: "Zhou Y et al. have conducted an indirect meta-analysis…
Sep 7, 2023, 19:34 |
Blog
,
Drugs
,
Insight
Shruti Patel: Tumor Board Tuesday - Mini tweetorial.
Shruti Patel, Oncology Fellow at Stanford Health Care, recently tweeted: "Tumor Board Tuesday - Mini…
All:
6
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube